Hu L, Xu Y, Qiao Y, Wang A, et al. The effectiveness and safety of immune checkpoint inhibitors in conversion or neoadjuvant therapy for hepatocellular carcinoma: a meta-analysis and systematic review. BMC Cancer 2025 Dec 23. doi: 10.1186/s12885-025-15449.
PMID: 41436995